CPRIT’s efforts are guided by an executive team that is committed to fulfilling CPRIT’s mission to find and fund the best cancer research and prevention projects in Texas.
Chief Executive Officer
Wayne Roberts was named Chief Executive Officer of the Cancer Prevention and Research Institute of Texas (CPRIT) in November 2013 after serving nearly a year as the Interim Executive Director. During that time, Mr. Roberts was retained to stabilize the agency which had undergone a series of operational crises and experienced legislative and public criticism. Throughout the 83rd Legislative Session, Roberts worked closely with the Texas legislature to strengthen the agency’s statutes, rules and regulations, and governance.
Margaret L. Kripke
Chief Scientific Officer
Dr. Kripke oversees CPRIT’s Research portfolio. Historically, CPRIT’s Research portfolio has funded the majority of the Institute’s $300 million in annual grant awards. Dr. Kripke retired in 2007 from The University of Texas MD Anderson Cancer Center where she was the executive vice president and chief academic officer. While there, she founded the Department of Immunology and was also a professor of immunology. She recently completed a nine-year term on the three-person President’s Cancer Panel, an honor reserved for the most distinguished oncology scientists in the nation.
Chief Prevention and Communications Officer
Dr. Rebecca Garcia heads up CPRIT’s prevention and communications efforts. Ten percent of CPRIT's total funding is dedicated to evidence-based prevention services. Her responsibilities include directing the prevention program and fostering collaboration among the cancer and disease prevention community to maximize CPRIT's impact. In addition, she is responsible for overseeing CPRIT’s strategic communications efforts.
Thomas C. Goodman
Chief Product Development Officer
Dr. Thomas Goodman oversees CPRIT’s portfolio of research and development grants directed toward commercial products. Prior to joining CPRIT, Dr. Goodman was Vice President of Business Development at Arizona Technology Enterprises, the technology transfer office of the Arizona State University. Prior to that, he was Vice President of Diagnostics at Valeo Medical where he directed the development of the company's immunoassay technology. Earlier he was a Director at Research Corporation Technologies where he participated in the selection and evaluation process for new venture investments and was responsible for out-licensing technologies.
Chief Advisor and General Counsel
Ms. Doyle is responsible for overseeing the legal issues that arise as part of CPRIT’s operations, including grant award contract negotiations, intellectual property and revenue sharing agreements, conflicts of interest and confidentiality, and regulatory/compliance issues. Prior to joining CPRIT, Ms. Doyle was a partner at an Austin-based law firm and served as Vice President of the Board of Directors for the Central Texas Chapter for the Leukemia and Lymphoma Society.
Chief Operating Officer
Ms. McConnell has oversight for CPRIT’s daily operations, including financial administration, grants management administration, communications, governmental relations, and information technology services. Most recently, she served as Senior Budget Advisor to Governor Rick Perry. In this capacity, she worked on a range of issues addressing the state budget and was the principal advisor on CPRIT.
David A. Reisman
Chief Compliance Officer
David A. Reisman is responsible for managing CPRIT’s compliance program. Prior to joining CPRIT, he served as Executive Director to the Texas Ethics Commission from October 11, 2004 until December 13, 2013.